Glaxosmithkline | GSK - Capitale Ordinario





Capitale Ordinario Cambiamento Data
AbbVie USD 1.77B 608K 2026-06
Amgen USD 541M 0 2026-09
AstraZeneca USD 1.55B 28K 2026-09
Aurora Cannabis CAD 63.31M 4.36M 2026-06
Bausch Health Companies USD 374.25M 351K 2026-09
Bristol-Myers Squibb USD 2.04B 7M 2026-06
Canopy Growth CAD 422.07M 53.78M 2026-03
Corcept Therapeutics USD 109.36M 1.44M 2026-09
Drreddys Laboratories INR 833.07M 382K 2026-09
Eli Lilly USD 943.5M 3.33M 2026-03
GlaxoSmithKline GBP 2.02B 2.05B 2026-09
Glaxosmithkline GBP 2.02B 2.03B 2026-09
J&J USD 2.41B 1.64M 2026-06
Merck USD 2.47B 1.05M 2026-06
Novartis USD 1.89B 12.09M 2026-09
Pacira USD 39.82M 512K 2026-06
Perrigo USD 138.8M 700K 2026-09
Pfizer USD 5.7B 0 2026-06
Phibro Animal Health USD 40.48M 0 2025-12
Prestige Brands USD 47.37M 53K 2026-06
Roche Holding CHF 796.77M 1.15M 2026-06
Sanofi EUR 1.2B 0 2026-09
Supernus Pharmaceuticals USD 58.16M 124K 2026-06
Takeda JPY 1.58B 460K 2026-06
Teva Pharmaceutical Industries USD 1.17B 2M 2026-09
Zoetis USD 407.49M 6.67M 2026-09